Abstract In a retrospective study we evaluated the agreement between the results of meta-iodo benzylguanidine (MIBG) scintigraphy and abdominal ultrasonography (US) in the diagnosis and follow up of neuroblastoma (NBL) with respect to the abdominal region. Data of 28 consecutive paediatric patients with NBL or suspected NBL were included (16 M/12 F, mean age 2.9 years, range 3 weeks ± 13.4 years). The results (as judged by the nuclear physician or radiologist, respectively) of 60 MIBG examinations ( 123 I and 131 I, including 26 single photon emission computed tomography (SPECT)) and US, respectively, performed within a period of 14 days, could be evaluated. Full agreement was reached in 37 comparisons (62%), while partial and no agreement was found in 17 (28%), and 6 (10%) comparisons, respectively. In 8 out of 37 comparisons with full agreement, 12 diagnosed lesions were histopathologically proven, while 11 comparisons with negative ®ndings were also negative in other clinical modalities. US diagnosed correctly in 68% of the histopathological proven lesions, while this was 54% for MIBG scintigraphy. In approximately 50% of the MIBG scans in which SPECT was available, SPECT provided signi®cant additional information.
Introduction
Neuroblastoma is the most common solid tumour of infancy and the most common extracranial solid tumour of childhood. It is a typical tumour of embryonal tissue, usually arising from the adrenal (medulla), or paravertebral sympathetic nervous system and localized most frequently in the abdomen [8, 27, 29] . Symptoms or signs of neuroblastoma are often vague [19] . Approximately 50% of infants and 70% of children above the age of 1 year have metastases at the time of diagnosis. It is still controversial whether mass screening in infants can improve the prognosis of the disease. Being supported by some [13, 22, 33] , (especially early) neuroblastoma screening faces scepticism by others [5, 6, 10, 14] due to the embryonic origin of the tumour paralleling with heterogeneous biologic features and clinical behaviour.
In the imaging of neuroblastoma, radiolabelled metaiodobenzylguanidine (MIBG) scintigraphy has been regarded particularly useful in distinguishing residual active tumour from masses composed of scar tissue [34] . Using 123 I or 131 I MIBG imaging, remote disease can be detected in one examination procedure [25] . Early 123 I MIBG images do have superior spatial resolution and counting statistics than can be obtained by tumour visualisation can be obtained using 131 I MIBG [17, 28] . Additional single photon emission computed tomography (SPECT) seems to improve the certainty of interpretation of the MIBG scan [11] .
Ultrasonography (US) is generally accepted as initial screening procedure in the imaging of neuroblastoma to assess the extent of the disease at the time of diagnosis and during follow up [8, 21] . Despite variations in its sonographic appearance, the speci®c sonographic feature of neuroblastoma could be a distinctive`lobule' of increased echogenicity in part of the larger mass [1] . In neonates, US can depict intraspinal components of neuroblastoma [30] . Presently, there is also a role for US in the prenatal diagnosis of neuroblastoma [12, 18, 19, 23, 24, 26, 32] . Diculties occasionally occur in the dierential diagnosis of nephroblastoma (Wilms tumour) [8, 27, 30] . A recent study [15] reported an identi®cation of the primary site in 96% of the NBL cases using abdominal US, and an 84% concordance between their US grading of neuroblastoma and the clinicopathological staging.
In this study, we analysed the agreement between the results of MIBG scintigraphy and US in the evaluation of children with abdominal neuroblastoma. Furthermore, the value of additional SPECT for the interpretation of the MIBG scan was evaluated.
Patients and methods

Patients
Data of 28 consecutive paediatric patients with neuroblastoma or suspected neuroblastoma who were referred to the Paediatric Oncology Department of the Academic Medical Centre (AMC), Amsterdam, the Netherlands between January 1993 and July 1995, were included in the study. There were 16 male and 12 female with a mean age of 2.9 years (range 3 weeks ± 13.4 years). In 22 patients, neuroblastoma was histologically proven, ganglioneuroblastoma in 5 patients, and ganglioneuroma in 1 patient. All patients underwent 131 I or 123 I MIBG-scintigraphy (whole body and/or SPECT) and US. In each patient, one to four MIBG scans and also one to four ultrasonographic studies were obtained with a mean of 2.46 MIBG scans and 2.25 US, respectively.
MIBG-scintigraphy
Thyroid iodine uptake was previously blocked using a saturated solution of potassium iodide (100 mg/day per os, starting 1 day before tracer administration for a period of 3 days ( 123 I) or 7 days ( 131 I)). In diagnostic studies, the intravenously administered dose was adjusted for length and weight, varying from 74±186 MegaBecquerels (2±5 mCi) for 123 I MIBG, and 18±74 MBq (0.5± 2 mCi) for A direct comparison between the results of the two diagnostic modalities could be made in 60 examination pairs, since they had been performed in the same patient within a period of 14 days. MIBG and US ®ndings in all 132 examinations were independently reviewed by an experienced nuclear physician and paediatric radiologist, respectively. The panel gave also an opinion about the additional value of SPECT, compared to planar images alone.
The images were judged as positive or negative if abdominal tumour masses were clearly present or absent, respectively. The result was called doubtful if the investigator was unsure about the result, or if arti®cial or technical problems impeded reliable judgement. Full agreement was achieved if both methods were positive on the same localisations, or if they agreed to be negative. Partial agreement was reached if both methods were not unanimous about the localisation of the pathology; or, if one of the two methods was doubtful. No agreement was concluded if one of the two methods was interpreted as negative for the whole abdominal region, while the other was positive.
Analysis of results
The results of both diagnostic methods, as judged by the attending nuclear physician and radiologist, respectively, were used for the evaluation of agreement. Outcome of agreement was measured in all 60 examination pairs. Furthermore, the outcome of agreement was compared in 14 patients (15 examination pairs) in which histological results after biopsy or surgery within one month after diagnostic imaging were available.
The grade of echogenicity of the primary tumour or metastases on US, the grade of tumour dierentiation based on pathological ®ndings after surgery and the (grade of ) uptake of corresponding (neuroblastoma) tumour lesions in MIBG scintigraphy were compared in 13 neuroblastoma lesions.
In 11 patients, the tumour MIBG uptake was calculated and compared with tumour size measurements (in three dimensions) in cm obtained by US.
Results
The results of the 60 comparisons between MIBG scintigraphy and US with regard to the detection and localisation of suspected abdominal neuroblastoma lesions are shown in Table 1 . Full agreement between the two imaging methods was found in 37 comparisons, 26 with pathology, and 11 without pathology. All 11 patients without pathology on both imaging methods were also negative by other clinical parameters (physical examination, blood chemistry, vanillylmandelic acid in the urine, CT or MRI). In 8 out of the 26``pathological'' comparisons, surgery and histopathology were available. In all eight comparisons (in eight patients), a total of 12 lesions seen by US and scintigraphy could be con®rmed, while six other lesions had not been detected by both methods. Figure 1 shows the posterior 131 I MIBG scan of a male of 10 months old, in which pathological MIBG uptake was reported in the region left paravertebral T10-L2. US diagnosed a tumour in the same area. This was proven by histopathology. Partial agreement was reached in 17 comparisons. In six comparisons (in ®ve patients), 18 tumour lesions could be histopathological proven, of which 12 were diagnosed correctly with US and 8 with MIBG scintigraphy. In one child, pathological lymph nodes were suspected on US examination, which could not be con®rmed at surgery, while MIBG was true negative. Figures 2 and 3 show two patients in which partial agreement was reached. No agreement was found in six comparisons, of which US in one of the patients was correct in one histopathological proven lesion. Figure 4 shows the 123 I MIBG scan and US of an 8-year-old girl in which the MIBG scan was completely negative, while the US diagnosed a large tumour in the right ovarial region. This was histopathologically con®rmed as neuroblastoma.
In summary, out of the 37 histopathologically proven lesions in 14 patients who underwent surgery within one month after the examinations, MIBG scintigraphy diagnosed correctly 20 (54%) of them, while US detected 25 (68%) of the lesions (Table 2) .
According to the opinion of the panel, 12 out of 26 SPECTs had signi®cant additional value to planar images: seven SPECTs had a decisive role in the degree of agreement, of which two were positive on SPECT, while negative or doubtful on planar whole body scintigraphy, and ®ve showed a higher number of detectable lesions, compared to the planar images. Another 5 out of the 26 SPECTs contributed considerably to the topographic information of the lesions.
Eight out of nine hyperechoic lesions (89%) were based on undierentiated neuroblastoma, while in three out of four hypoechoic lesions (75%) were histopathologically recognized as neuroblastoma with various extents of ganglionic dierentiation. Two out of the three cases of dierentiated neuroblastoma did not show pathological MIBG-uptake at all. Another two patients demonstrated conversion of hyperechoic into hypoechoic lesions on serial sonograms, while there were clinical signs of spontaneous tumour regression in one and therapy induced tumour regression in the other case, respectively.
The tumour MIBG uptake after 24 h (seven patients) and 48 h (four other patients) after tracer administration was mean 2.5% (range 0.02%±9.9%) and 7.52% (range 0.7%±26%), respectively. Ultrasonographically obtained tumour diameters were mean 5.1 cm (range 1± 16 cm). No correlation could be found between MIBG uptake and ultrasonographically measured tumour size.
Discussion
In the diagnostic management of a child with suspected neuroblastoma, US is currently the most frequently used imaging modality because of its non-invasiveness [8, 21] . There is no doubt about its suboptimal position with respect to CT and/or MRI in the assessment of the extent of disease at any clinical condition [4, 27, 31] . On the other hand, the role of radionuclide MIBG scintigraphy, showing vital neuroblastoma tissue sensitively and selectively, is increasing, not only for the diagnosis and staging, but also for the follow up of the therapy [4, 16] .
In this study, we compared retrospectively the results of abdominal ultrasonography and 123 I or 131 I MIBG scintigraphy in 60 examination pairs, performed in 28 consecutive paediatric patients who were suspected for (abdominal) neuroblastoma. In 62% of the comparisons, full agreement between the two methods was reached. All 11 negative patients were clinically proved to be true negative. It was also found that in this group, in 12 histopathologically proven lesions in 8 patients, both diagnostic methods demonstrated corresponding ®ndings, while six other lesions were missed by both methods. These six missed lesions were not relevant to the clinical pathological status of the patients and had therefore no therapeutical consequences. Thus, a similar result of US and MIBG scintigraphy seems to be reliable in diagnosing and locating abdominal lesions of neuroblastoma.
Partial and no agreement were found in a total of 38% comparisons. Out of the 19 histopathological proven lesions, 13 were true positive with US, and 8 with MIBG scintigraphy. None of the 19 lesions were missed by one of the two method, suggesting a complementary role of both imaging methods. A reason for disagreement was for instance the diculty of the interpretation of the adrenal region in planar MIBG scintigraphy if there was physiological adrenal uptake or overprojection of physiological liver uptake (four comparisons) I MIBG whole body scan of an 8-year-old girl, which was interpreted as normal. B US of the small pelvis with a large hypoechoic solid mass in the right adnex region, sized 4´3´3 cm. A neuroblastoma was histopathologically con®rmed [27, 30] . Especially after surgery of a suprarenal neuroblastoma, intense uptake may be found in the remnant non-tumourous adrenal medulla due to functional compensation (hyperplasia) which leads to increased uptake of the radiolabelled MIBG [3, 25] . With US, the interpretation of the adrenal glands in children under the age of 1 year seems to be dicult, because of the difference in (physiological) volume of the adrenals (left > right in two instances), and also because the echogenicity changes from hyperechoic in younger children to hypoechoic above the age of 1 year due to the disappearance of ®brous tissue [20] . Planar MIBG scintigraphy may miss pathological lymph node metastases (three instances) [23, 25] . On the other hand, pathological lymph nodes can be false positively suspected on US examination which can be explained by reactive and in¯ammatory mechanisms due to (tumour) disease (one instance). Controversely, the interpretation of US is easier if pathological lymph nodes involved by neuroblastoma are calci®ed [27] . Spleen in®ltration, suggested by MIBG scintigraphy in two of our patients, is generally unusual in neuroblastoma, while massive hepatomegaly, secondary to tumour in®ltration, might simulate spleen involvement, especially in children with stage IVs disease younger than 6 months [7] . A falsenegative MIBG scan may occur in a patient with liver involvement if 123 I MIBG is used (one instance) [9] . Although there is no characteristic sonographical appearance of metastatic disease in the liver, US seems to be superior to MIBG scintigraphy in this matter [27, 35] .
In approximately 50% of the MIBG scans in which SPECT was available, SPECT provided signi®cant additional information by means of the visualisation of a higher number of lesions and/or improvement of the topographic information of the lesions. Therefore, it seems to be advisable to perform abdominal MIBG SPECT routinely in the diagnosis and follow up of neuroblastoma. This is contradictionary to the statement of Gelfand et al. [11] that 123 I MIBG-SPECT does not increase the number of lesions detected in the torso compared with the results of planar imaging.
In conclusion, in the diagnostic management of patients with suspected or known abdominal localisations of neuroblastoma, full agreement between US and MIBG scintigraphy indicates a high reliability in diagnosing and localising abdominal neuroblastoma. In 50% of the MIBG scans in which SPECT was available, a higher number of lesions could be found or an improvement of the topographic information of the lesions was reached. Routinely performance of additional MIBG SPECT and combinated judgement of both imaging modalities may therefore improve the accuracy of the diagnostic procedure.
